{"organizations": [], "uuid": "6ff166aeae31bf19711d05994e9e2950030a5d7a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180116.html", "section_title": "Archive News &amp; Video for Tuesday, 16 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-sinclair-pharma-says-gets-regulato/brief-sinclair-pharma-says-gets-regulatory-approval-of-ellanse-by-anvisa-in-brazil-idUSFWN1PB01P", "country": "US", "domain_rank": 408, "title": "BRIEF-Sinclair Pharma Says Gets Regulatory Approval Of Ellanse By Anvisa In Brazil​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.925, "site_type": "news", "published": "2018-01-16T15:37:00.000+02:00", "replies_count": 0, "uuid": "6ff166aeae31bf19711d05994e9e2950030a5d7a"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-sinclair-pharma-says-gets-regulato/brief-sinclair-pharma-says-gets-regulatory-approval-of-ellanse-by-anvisa-in-brazil-idUSFWN1PB01P", "ord_in_thread": 0, "title": "BRIEF-Sinclair Pharma Says Gets Regulatory Approval Of Ellanse By Anvisa In Brazil​", "locations": [], "entities": {"persons": [], "locations": [{"name": "brazil", "sentiment": "none"}, {"name": "brazil", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "sinclair pharma plc", "sentiment": "negative"}, {"name": "brief-sinclair pharma says gets regulatory approval of ellanse", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 16 (Reuters) - Sinclair Pharma Plc:\n* ‍ANNOUNCE THAT IT HAS RECEIVED REGULATORY APPROVAL OF ELLANSÉ® BY ANVISA IN BRAZIL​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-16T15:37:00.000+02:00", "crawled": "2018-01-17T19:45:20.022+02:00", "highlightTitle": ""}